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STUDIES ON AXON REFLEX VASODILATATION AND
CIHOLINERGIC URTICARIA*
ALLAN L. LORINCZ, M.D. AND ROGER W. PEARSON, M.D.
Despite the likelihood that at least part of the
erythema in many cutaneous inflammatory proc-
esses may he due to axon reflex vasodilatation,
the chemical mediator of this important vascular
response (which seems to be also the mediator of
so-called antidromic vasodilatation) remains un-
identified. The usually suggested mechanism for
this vasodilatory response, the classic example of
which is the histamine flare, is that it results
directly from the action of acetylcholine released
at vascular endings. In the past some workers
presented evidence as reviewed recently by Par-
rot (1) and Rothman (2) that this hypothesis
failed to account for certain contradictory ob-
servations. In this report additional evidence is
presented which almost certainly excludes acetyl-
choline as the neurohumoral agent involved.
Other observations which argue against either
histamine as first suggested by Lewis (3) or
serotonin being the agent in question are also
described.
In the course of these studies two patients
with classical cholinergic urticaria were examined.
In addition to confirming the previous observa-
tions (4, 5) that satellite wheals do not appear in
the flare areas about histamine wheals in such
patients, some other observations were made and
will be discussed.
We believe on the basis of considerations to be
presented that there appear to be good reasons
for postulating and searching for a new type of
physiological neurohumoral vasodilating sub-
stance. Such a substance would have obvious
dermatologic significance.
MATERIALS AND METHODS
A. Experiments on Vasodilatation in Normal
Subjects
Axon reflex vasodilatation was induced by
intradermal injection of histamine phosphate
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1/10,000. Direct histamine-induced vasodilata-
tion was elicited by intradermal injection of
subwhealing concentrations of histamine phos-
phate, 1/2,000,000. Direct acetylcholine and
serotonin vasodilatations were produced by ionto-
phoresis of aqueous solutions of each (1/200
acetylcholine chloride and 1/10,000 5-hydroxy-
tryptamine creatine sulfate) for one to four
minutes at two milliamperes. Suitable saline
and/or distilled water controls were used in all
instances.
The following substances were injected intra-
dermally at various intervals before and after
induction of erythema by the above methods,
and their effects noted:
a. atropine sulfate 1/25,000—1/250,000
b. prostigmine methylsulfate 1/10,000—1/40,-
000
c. nicotine picrate 1/1,000—1/100,000
d. Cyclaine® (hexylaine) hydrochloride 1/100
e. Benadryl® (diphenhydramine) hydrochlo-
ride 1/1,000—1/200,000
f. Marsilid® (iproniazid) dihydrochloride4
1/40
g. BOL-14S (2-bromo-d-lysergic acid diethyl-
amide tartrate) 1/2,000
h. d-tubocurarine chloride 1/2,000,000 (anti-
nicotinic)
B. Experiments on Patients with Cholinergic
Urticaria
Two patients were studied.
Case 1. A 24 year old white male medical stu-
dent had a three year history of tiny "hives"
appearing after mild exercise, in warm environ-
ment, or when under emotional tension. When
episodes were severe, nausea and dizziness were
noted. On one occasion after severe exercise, the
patient became unconscious. During an attack
a generalized eruption appeared which lasted
several hours and was more marked on the
flexural aspects of the upper half of the body,
sparing palms and soles. The lesions were bright
red irregular macules 2—20 millimeters in diame-
ter, many of which had central 2—4 millimeter
t Supplied by Merck, Sharp and Dobme.
t Supplied by Hoffman-LaRoehe, Inc.§ Supplied by Sandoz Chemicals, Inc.
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wheals. The eruption could he ameliorated with
systemically administered antihistamines and
avoidance of known aggravating conditions.
Case 2. A 30 year old white male efficiency
engineer had a six-month history of transient
pruritic papules over most of the body, occurring
after exercise, excitement, or heat. Examination
showed typical 1—15 millimeter red macules,
many with central 2—4 millimeter wheals. Anti-
histamines have been of help in controlling the
attacks.
The results of the following procedures were
observed:
1. Histamine flare response produced by hista-
mine phosphate 1/10,000, 0.1 cc. injected
intradermally.
2. Axon reflex release of acetylcholine by intra-
dermal injection of nicotine picrate 1/50,-
000—1/100,000, and mecholyl chloride 1/5,-
000.
3. lontophoresis of acetyicholine 1/200 (2 ma.
for 1—4 minutes).
4. Attempts to inhibit or prolong reactions
produced by the above measures by prior
intradermal injections of atropine sulfate
(1/25,000—1/250,000), and prostigmine (1 /
10,000—1/40,000).
5. Production of local sweating by infra-red
irradiation. One-half of the irradiated area
was prepared for demonstration of sweating
by a modification of Minor's method (6).
Irradiation was continued until near maxi-
mal sweating was obtained.
C. Experiments on Vein Collapse in Normal
Subjects
Serotonin causes collapse of the surrounding
large subcutaneous veins when introduced into
the skin (7). Attempts to inhibit the phenomenon
were made by intradermal injection of the fol-
lowing substances prior to introduction of sero-
tonin by intradermal injection (l—lOy in 0.1 cc.
saline) or by iontophoresis: Cyclaine® hydro-
chloride 1/100, Benadryl® hydrochloride 1/100,
and BOL-148 1/2,000. The effect of intradermal
injection of a mixture of BOL-148 and serotonin
(1/4,000 and 1/20,000 respectively) was also
noted. Additionally, attempts to prolong the
phenomena by intradermal injection of Marsilid®
1/40 were made.
OBSERVATIONS
A. In Normal Subjects
1. Attempts to Inhibit or Prolong the Histamine
Flare. Areas on the forearms of six normal young
adult subjects were prepared by intradermal in-
jections of the agents already indicated. As soon
as injection wheals flattened somewhat, axon
reflex flares were produced with histamine to
include the prepared areas. Only Benadryl® in
anesthetic concentrations (1/1,000) and Cy-
elaine® affected the flare, inhibition resulting in
all subjects. Benadryl® in less than local anes-
thetic concentrations (1/100,000) had no effect
on axon reflex flares. When the local anesthetics
were injected into established flares, no inhibition
was noted.
2. Attempts to Inhibit or Prolong Local Acetyl-
choline-Induced Vasodilatation. The forearms of
four normal subjects were prepared with prostig-
mine, Cyclaine®, atropine, BOL-148, nicotine
picrate, and saline as previously described, and
acetyleholine iontophoresis was performed to
include the prepared areas. Distilled water and/or
saline were introduced by iontophoresis into
similarly prepared areas on the other forearm.
In the experimental areas in all subjects, there
was noted striking inhibition of direct acetyl-
choline-induced erythema by atropine and pro-
longation by prostigmine. Control sites ionto-
phoresed with saline showed only minimal,
transient erythema incidental to the iontophoresis
procedure.
3. Inhibition of Direct Histamine-Induced
Erythema. Direct erythema produced in normal
subjects by histamine salt solution (1/2,000,000)
was readily inhibited by less than local anes-
thetic concentrations of Benadryl® (1/100,000
and 1/200,000). Such concentrations of Bena-
dryl® fail to affect axon reflex vasodilatation.
4. Attempts to Inhibit or Prolong Erythema
Produced by Serotonin lontophoresis. The experi-
mental procedure was identical to that described
in section two above except that serotonin was
substituted for acetylcholine. No notable effect
on the erythema was noted at any of the test
sites. During the procedure active collapse of
the large subcutaneous veins for 1—3 or more
centimeters surrounding the area of iontophoresis
was noted. This phenomenon of serotonin-induced
constriction of large subcutaneous veins was
first noted by Reid (7) in 1952. The collapse ex-
tended beyond areas where there were visible
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color changes in the overlying skin from sero-
tonin.
5. Attempts to Inhibit the Vein Collapse Phe-
nomenon. lontophoresis or injection of serotonin
through areas prepared with intradermal injec-
tion of Cyclaine®, Benadryl®, BOL-148, and
Marsilid® in the concentrations already men-
tioned, did not modify the elicitation of the
phenomenon in any way. If a tourniquet was
placed alongside the site of serotonin injection,
the veins distal to the tourniquet failed to col-
lapse.
B. In Patients with Cholinergic Urticaria
In performing diagnostic or experimental ex-
aminations in patients with cholinergic urticaria,
it is of great importance that care be given to
the timing of procedures. If the eruption is
present or has been present within a few hours,
it is best to defer the procedures or repeat them
later on, because generally patients have re-
fractory periods after an attack for as long as 12
or 24 hours. If a patient has been receiving anti-
histamines, it may be as long as 2 or 3 days after
the medication is stopped for the whealing
reaction to become characteristic.
In our patients, the following observations
were made:
1. Satellite wheals did not develop in axon
reflex flares induced by histamine.
2. Acetyleholine iontophoresis to the point of
minimal erythema regularly resulted in the
appearance of typical 1—3 millimeter wheals
in the area of iontophoresis, and occasion-
ally also satellite wheals in the immediately
surrounding non-erythematous area.
3. Nicotine picrate 1/50,000—1/100,000 intra-
dermally was regularly followed by the
appearance in 3—10 minutes of 1—2 milli-
meter satellite wheals typical of those
naturally occurring in the disease. Mecholyl
gave similar results, but also a variable
wheal reaction at the injection site.
4. Atropine injected locally prevented the
appearance of naturally produced lesions
(exercise), and also prevented the direct
whealing response to acetylcholine ionto-
phoresis in the atropinized areas. The
satellite wheal phenomenon was also sup-
pressed.
5. Naturally produced lesions, lesions elicited
by direct acetylcholine iontophoresis, and
FJG. 1. Failure of direct heat sweating to induce wheals in a patient with cholinergic urticaria. The
left half of the irradiated area was prepared for demonstration of sweating by Wada's method.
/1*
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satellite lesions produced by the methods
described in section B-2 were all locally
intensified in number and duration by
intradermal prostigmine injections.
6. Local direct heat sweating was not ac-
companied by whealing (Fig. 1).
DI 5U55ION
The theory that axon reflex vasodilatation
and antidromic vasodilatation are mediated by
nerves having their cell bodies in the dorsal root
ganglia and running peripherally with the sen-
sory nerves has strong experimental support (8,
9, 10). The neurohumoral mediator is in all
probability the same in both reactions; indeed,
the very same nerves are probably involved.
Dale and Gaddum (11) suggested in 1930 that
the vasodilator substance could be acetyleholine.
Later Wybauw (12, 13, 14, 15) identified acetyl-
choline in perfusion fluid returning from limbs in
which antidromic vasodilatation had been in-
duced. In the flare of human histamine wheals
Rothman and Coon (16) were able to demonstrate
acetyleholine. More recently the acetyleholine
theory has received support from the studies of
Rajka et al. (17) who claimed they could inhibit
the vasodilatory reflex with parasympatholyties
and by Scott (18) who demonstrated acetyl-
eholinesterase by histoehemical means in sensory
nerve twigs to arterioles.
In the present work it has been demonstrated
that the axon reflex flare about the histamine
wheal is not inhibited by atropine or by paralyz-
ing concentrations of nicotine and is not pro-
longed by prostigmine. Moreover, it was demon-
strated that direct vasodilatation induced with
acetyleholine is based upon its musearinic action
as evidenced by inhibition with atropine and
prolongation by prostigmine. These observations
afford strong evidence that aeetylcholine itself
cannot be the vasodilatory substance involved in
the axon reflex flare.
In cholinergic urtiearia the lesions of the dis-
ease are typically tiny two to four millimeter,
histaminic wheals, usually surrounded by bright
erythema. They are produced in the natural
disease when acetyleholine is released in the skin
at cholinergic nerve endings. The usual stimuli
for this release are heat, exercise, or emotional
tension, the same stimuli that initiate sweating.
Under physiologic conditions sweating is brought
about by release of acetyleholine at nerve end-
ings supplying sweat glands. The abnormal reac-
tion to aeetylcholine in cholinergic urtiearia,
whatever its pathogenic mechanism which finally
leads to release of histamine, would be expected
to occur at sudoriferous nerve endings.
Rothman and Coon (19) showed that intra-
dermal injection of nicotine salts (or any agent
with nieotinic action) in proper concentrations
induces axon reflex sweating which is mediated
apparently by the very same cholinergic nerve
fibers which trigger physiologic sweating. The
sweating so induced involves an area several
centimeters in diameter. As demonstrated re-
cently by Herxheimer (5), in individuals with
eholinergic urticaria, tiny wheals exactly like
those occurring in the disorder in response to
natural eliciting stimuli, appear in such areas of
axon reflex sweating. These are the so-called
satellite wheals.
lontophoresis of aeetylcholine even in amounts
just sufficient to elicit minimal erythema in the
skins of patients with cholinergic urtiearia pro-
duces typical wheals in the area of iontophoresis,
as well as satellite wheals in the surrounding
area by the axon reflex mechanism. The observa-
tion that satellite wheals do not appear in hista-
mine flares of patients with cholinergic urticaria
offers additional evidence against the assumption
that axon reflex vasodilatation is cholinergie. It
should he mentioned however, that Lewis (20)
did report a ease, which despite atypical features
he considered to be cholinergic urticaria, in
which he observed satellite wheals in areas of
histamine-induced axon reflex flare. In eliciting
these satellite lesions he used very strong hista-
mine solutions (1/300). As suggested by Herx-
heimer (5), these strong histamine solutions
might also have elicited sufficient cholinergie
axon reflex sweating to account for the satellite
wheals. An alternative possibility is that Lewis
was actually dealing with a patient in whom the
unknown substance responsible for axon reflex
vasodilatation was triggering urticaria. No other
similar case has been reported. Furthermore,
Lewis' theory that the axon reflex flare might be
mediated by histamine (3, 20) could not be sub-
stantiated, because antihistamine (Benadryl®
1/100,000) did not inhibit the histamine flare
but readily did inhibit erythema elicited by sub-
whealing concentrations of histamine.
The recent great interest in the vasoactive
amine, serotonin (SilT) prompted us to consider
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it as a possible mediator of axon reflex and anti-
dromic vasodilatation. Although it has been
shown that BOL-148 is an antagonist to SilT
(21), and Marsilid®, by being a monoamine
oxidase inhibitor can prolong the action of 5HT
(22), with the local methods and concentrations
used in these experiments we were unable to
demonstrate any influence of these agents on the
cutaneous effects of SilT. These agents under
the experimental conditions used also bad no
effect on the histamine flare. Two facts suggest
that 5111' is not the vasodilator substance in
question. First, in most subjects, as noted by
Reid (7), no erytbema-indueing effect of SilT
injected intradermally is found until the concen-
tration reaches 1/200,000, whereas the reported
maximum concentration of SilT available in
human skin is approximately 1/100,000,000 (23).
Of course, more 5HT might be present in some
bound form not yet demonstrated. Second, when
histamine flares are produced no vein collapse is
noted, though concentrations far in excess of
that required to give collapse would bave to be
present in order to produce the erythema. Inci-
dentally, the vein collapse phenomenon appears
to result from simple diffusion and the direct
venoeonstrietor action of SilT. We speculated
about a possible axon reflex mechanism because
the effect was usually sharply demarcated. How-
ever, we were unable to prevent it by local
anesthetics but could readily prevent it by a
tourniquet between the site of injection and the
observed vein.
Inasmuch as none of the above suggested
mediators for axon reflex vasodilatation appear
satisfactory, the experiments a decade ago of
Hellauer and TJmrath (24) deserve more careful
consideration. They extracted a substance from
dorsal roots which, when injected into normal or
denervated rabbit ears, caused a slowly develop-
ing, deep red flush. They demonstrated that this
unidentified substance was neither aeetyleholine
nor histamine. Their substance may or may not
be the vasodilatory substance in question but it
is for such an agent and its identification that a
renewed search should be undertaken. linger and
Parrot and their associates in a series of reports
also presented evidence for the existence of a
unique vasodilatory neurohumeral substance re-
sembling histamine but not identical with it (1)
and Holton and Holton even suggested that this
agent might be ATP or ADP (25).
In considering the pathogenesis of eholinergic
urtiearia, it appears that true allergy to aeetyl-
choline on the basis of an antibody reaction is
not involved. If there were allergy, local atro-
pinization, long known to suppress eholinergie
urtiearia (26), which acts by blocking the mus-
earinie action of aeetyleholine at the receptor
site, should have no effect on the condition.
Failure of passive transfer, while not conclusive
by itself, provides additional evidence against
an allergic mechanism. The fact that eholinergie
urtiearia clinically fails to respond well to systemic
administration of anticholinergie agents is
probably related to the high tissue concentration
of these agents required to effectively block
aeetyleholine-effeeted histamine release to the
degree so easily attained by local injection.
Sweat glands can be directly stimulated to
secrete sweat by local heat (2). This direct heat
sweating is not based on activation of the eho-
linergie innervation to sweat glands. Inasmuch as
such direct heat sweating failed to elicit lesions
in persons with eholinergie urtiearia, sweating
alone or some metabolic product associated with
sweating does not appear to be involved in the
triggering of histamine release in the disorder as
suggested by ilerxheimer (5). It had previously
been noted that sweat itself inj eeted locally pro-
duces no whealing in eholinergie urtiearia pa-
tients (26), though a recent report (27) suggests
that some normal persons and especially atopie
individuals do sometimes urticate in response
to intraeutaneous injection of sweat.
For the practical clinical purpose of skin test-
ing for eholinergie urtiearia the following con-
siderations are noteworthy. First, care must be
taken to avoid testing during a refractory period
which may last for hours after severe outbreaks
of the lesions. Second, the appearance of satellite
wheals in areas in which axon reflex sweating
has been elicited provides a more easily inter-
preted and critical test phenomenon than local
excessive whealing to injections of eholinergie
drugs. Intradermal injections of dilute solutions
of nicotine salts (1/50,000—1/100,000) appear
more satisfactory than eholinergie agents with
nieotinie effects for elicitation of the satellite
whealing phenomenon in testing for eholinergie
urtiearia. Such nicotine salt solutions are much
more stable and there is no confusing direct local
whealing such as occurs with the eholinergie
agents. If, however, cholinergie agents are used
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for testing, care must be taken to select a con-
centration for intradermal injection which is in
the range known to elicit axon reflex sweating.
With acetyicholine, for example, this range lies
between 1/10,000 and 1/80,000 (19).
SUMMARY
The question of the neurohumoral mediator
of axon reflex vasodilatation was examined and
evidence has been presented which indicates
that this mediator is not acetylcholine, histamine,
or serotonin.
Observations were made in two patients with
cholinergic urticaria. Sweating induced locally
by direct heat did not elicit lesions of the disorder
such as were precipitated by activation of the
cholinergic innervation to sweat glands. Intra-
dermal injections of dilute solutions of nicotine
salts which are very stable provide via the satel-
lite or axon reflex wheal phenomenon a conven-
ient and easily interpreted test for eholinergie
urticaria.
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DISCUSSION
DR. PETER FLESCE (Philadephia, Penna.): Dr. that an unknown substance may be responsible
Lorinez is probably correct in his assumption for vasodilatation in the skin. Unfortunately, it
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is difficult to conduct such studies and to reach
definite conclusions. To mention one possible
pitfall alone: atropine, in addition to its anti-
eholinergic action, also releases histamine and
causes whealing. It is also difficult to explain
why, often, patients with eholinergie urticaria will
respond with whealing to different types of
stimuli. In some, whealing is produced by pres-
sure alone, in others by pinching, still in others
by heat. There is no ready explanation for this
phenomenon.
I would like to ask Dr. Lorincz how he would
explain the occurrence of satellite wheals after
the introduction of stable choline esters, as has
been observed previously.
DR. ALLAN L. L0RINcZ (in closing): In response
to Dr. Flesch, the fact that atropine is a hista-
mine-releasing agent supports, if anything, the
view that axon reflex vasodilatation is not medi-
ated by histamine. If this vasodilatation were
mediated by histamine, one would expect prior
atropinization to cause local exhaustion of hista-
mine stores and temporary refractoriness or
non-responsiveness of the atropinized area. Local
atropinization, however, failed to interfere with
the subsequent development of axon reflex
erythema in the treated area. In referring to the
case reported by Sir Thomas Lewis, I believe Dr.
Flesch had in mind the individual in whom
satellite wheals did appear in axon reflex flare-
areas about histamine wheals. Although Lewis
described the clinical disorder in this case as
cholinergic urticaria there were a number of
atypical features present. Furthermore, absence
of satellite wheals in histamine flare-are s has
been the rule in all classical cases of cholinergic
urtiearia observed for this phenomenon since
then. Possibly Lewis' atypical case had urticarial
hypersensitivity to the unknown mediator we are
seeking rather than to acetyleholine.
In considering vasodilatation or flushing it is
evident that a great variety of different agents
such as acetylcholine, histamine, serotonin,
nicotinic acid or its esters, etc. can produce it.
Axon reflex vasodilatation, as was pointed out
however, has pharmacophysiologic features which
suggest that it is mediated by a still to be identi-
fied neurohumoral substance.
